Publications

Found 2 results
Filters: Author is X.C. Zhou  [Clear All Filters]
2012
Y. M. Zhang, Zhou, X. C., Xu, Z., and Tang, C. J., Meta-analysis of epidemiological studies of association of two polymorphisms in the interleukin-10 gene promoter and colorectal cancer risk, vol. 11, pp. 3389-3397, 2012.
Baniyash M (2006). Chronic inflammation, immunosuppression and cancer: new insights and outlook. Semin. Cancer Biol. 16: 80-88. http://dx.doi.org/10.1016/j.semcancer.2005.12.002 PMid:16420981   Breslow NE and Day NE (1987). Statistical methods in cancer research. Volume II - The design and analysis of cohort studies. IARC Sci. Publ.1-406.   Bulpitt EA, Baynesc C, Dunning AM, Evans PR, et al. (2004). Investigation of interleukin-10 and vascular endothelial growth factor single nucleotide polymorphisms in predisposition to breast cancer. Genes Immun. 5: S1-S53.   Cacev T, Radosevic S, Krizanac S and Kapitanovic S (2008). Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 29: 1572-1580. http://dx.doi.org/10.1093/carcin/bgn164 PMid:18628251   Chan AT, Ogino S and Fuchs CS (2007). Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N. Engl. J. Med. 356: 2131-2142. http://dx.doi.org/10.1056/NEJMoa067208 PMid:17522398   Cozar JM, Romero JM, Aptsiauri N, Vazquez F, et al. (2007). High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Hum. Immunol. 68: 698-704. http://dx.doi.org/10.1016/j.humimm.2007.05.002 PMid:17678726   Crawley E, Kay R, Sillibourne J, Patel P, et al. (1999). Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum. 42: 1101-1108. http://dx.doi.org/10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y   Crivello A, Giacalone A, Vaglica M, Scola L, et al. (2006). Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma. Ann. N. Y. Acad. Sci. 1089: 98-103. http://dx.doi.org/10.1196/annals.1386.002 PMid:17261758   Crohn BB and Rosenberg H (1925). The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Am. J. Med. Sci. 170: 220-228. http://dx.doi.org/10.1097/00000441-192508010-00006   De Vita F, Orditura M, Galizia G, Romano C, et al. (1999). Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer 86: 1936-1943. http://dx.doi.org/10.1002/(SICI)1097-0142(19991115)86:10<1936::AID-CNCR9>3.0.CO;2-9   Eskdale J, Kube D, Tesch H and Gallagher G (1997). Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics 46: 120-128. http://dx.doi.org/10.1007/s002510050250 PMid:9162098   Eskdale J, Gallagher G, Verweij CL, Keijsers V, et al. (1998). Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc. Natl. Acad. Sci. U. S. A. 95: 9465-9470. http://dx.doi.org/10.1073/pnas.95.16.9465 PMid:9689103 PMCid:21361   Gunter MJ, Canzian F, Landi S, Chanock SJ, et al. (2006). Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol. Biomarkers Prev. 15: 1126-1131. http://dx.doi.org/10.1158/1055-9965.EPI-06-0042 PMid:16775170   Hanada T and Yoshimura A (2002). Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 13: 413-421. http://dx.doi.org/10.1016/S1359-6101(02)00026-6   Howell WM and Rose-Zerilli MJ (2007). Cytokine gene polymorphisms, cancer susceptibility, and prognosis. J. Nutr. 137: 194S-199S. PMid:17182825   Lakatos PL and Lakatos L (2008). Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J. Gastroenterol. 14: 3937-3947. http://dx.doi.org/10.3748/wjg.14.3937 PMid:18609676 PMCid:2725331   Lee YS, Choi HB, Lee IK, Kim TG, et al. (2010). Association between interleukin-4R and TGF-beta1 gene polymorphisms and the risk of colorectal cancer in a Korean population. Colorectal Dis. 12: 1208-1212. http://dx.doi.org/10.1111/j.1463-1318.2009.02080.x PMid:19863607   Macarthur M, Sharp L, Hold GL, Little J, et al. (2005). The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland. Cancer Epidemiol. Biomarkers Prev. 14: 1613-1618. http://dx.doi.org/10.1158/1055-9965.EPI-04-0878 PMid:16030091   Midgette AS, Wong JB, Beshansky JR, Porath A, et al. (1994). Cost - Effectiueness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction. Med. Decis. Making 14: 108-117. http://dx.doi.org/10.1177/0272989X9401400203 PMid:8028463   Shin HD, Park BL, Kim LH, Jung JH, et al. (2003). Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum. Mol. Genet. 12: 901-906. http://dx.doi.org/10.1093/hmg/ddg104 PMid:12668613   Siegel R, Naishadham D and Jemal A (2012). Cancer statistics, 2012. CA Cancer J. Clin. 62: 10-29. http://dx.doi.org/10.3322/caac.20138 PMid:22237781   Sturlan S, Oberhuber G, Beinhauer BG, Tichy B, et al. (2001). Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development. Carcinogenesis 22: 665-671. http://dx.doi.org/10.1093/carcin/22.4.665 PMid:11285204   Talseth BA, Meldrum C, Suchy J, Kurzawski G, et al. (2007). Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer. Scand. J. Gastroenterol. 42: 628-632. http://dx.doi.org/10.1080/00365520601106699 PMid:17454884   Triantafillidis JK, Nasioulas G and Kosmidis PA (2009). Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res. 29: 2727-2737. PMid:19596953   Tsilidis KK, Helzlsouer KJ, Smith MW, Grinberg V, et al. (2009). Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control. 20: 1739-1751. http://dx.doi.org/10.1007/s10552-009-9427-7 PMid:19760027   Tuynman JB, Peppelenbosch MP and Richel DJ (2004). COX-2 inhibition as a tool to treat and prevent colorectal cancer. Crit. Rev. Oncol. Hematol. 52: 81-101. PMid:15501074   Vidal-Vanaclocha F (2009). Inflammation in the molecular pathogenesis of cancer and atherosclerosis. Reumatol. Clin. 5S1: 40-43.   Vogel U, Christensen J, Dybdahl M, Friis S, et al. (2007). Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutat. Res. 624: 88-100. http://dx.doi.org/10.1016/j.mrfmmm.2007.04.006 PMid:17544013   Wilkening S, Tavelin B, Canzian F, Enquist K, et al. (2008). Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis 29: 1202-1206. http://dx.doi.org/10.1093/carcin/bgn101 PMid:18448485   Xie J and Itzkowitz SH (2008). Cancer in inflammatory bowel disease. World J. Gastroenterol. 14: 378-389. http://dx.doi.org/10.3748/wjg.14.378 PMid:18200660 PMCid:2679126   Zheng C, Huang D, Liu L, Wu R, et al. (2001). Interleukin-10 gene promoter polymorphisms in multiple myeloma. Int. J. Cancer 95: 184-188. http://dx.doi.org/10.1002/1097-0215(20010520)95:3<184::AID-IJC1031>3.0.CO;2-V